{"id":"4a917c15-58a2-46d4-b764-42e3d7e40053","dataset":"sourcesCorporatePublication","time":8,"normalizedUIQL":null,"lastDatasetUpdate":"2019-02-16T00:12:36Z","PagedResults":{"total":151,"firstRow":11,"lastRow":20,"Result":[{"Field":[{"name":"sourceId","type":"string","value":"446138"},{"name":"corporatePublicationTitle","type":"string","value":"Annual Report 2001: Ono Pharmaceutical Co Ltd - Dedicated to Man's fight against disease and pain"},{"name":"corporatePublicationType","type":"string","value":"Annual Report"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2001-06-28T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"Ono Pharmaceutical Co Ltd"}],"pos":11},{"Field":[{"name":"sourceId","type":"string","value":"424770"},{"name":"corporatePublicationTitle","type":"string","value":"AstraZeneca research: cardiovascular, central nervous system, gastrointestinal, infection, oncology, pain control &amp; anaesthesia and respiratory"},{"name":"corporatePublicationType","type":"string","value":"Company World Wide Web site"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2001-10-09T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"AstraZeneca plc"}],"pos":12},{"Field":[{"name":"sourceId","type":"string","value":"435316"},{"name":"corporatePublicationTitle","type":"string","value":"Neurology CEDD disease area strategy/ Pain"},{"name":"corporatePublicationType","type":"string","value":"Company Brochure"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2001-11-01T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"GlaxoSmithKline plc"}],"pos":13},{"Field":[{"name":"sourceId","type":"string","value":"441966"},{"name":"corporatePublicationTitle","type":"string","value":"ZeP-3: a synthetic drug of natural origin for chronic pain"},{"name":"corporatePublicationType","type":"string","value":"Company World Wide Web site"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2002-03-04T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"Shulov Institute for Science Ltd"}],"pos":14},{"Field":[{"name":"sourceId","type":"string","value":"443409"},{"name":"corporatePublicationTitle","type":"string","value":"Drug development pipeline: MorViva"},{"name":"corporatePublicationType","type":"string","value":"Company Communication"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2002-03-13T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"Pain Therapeutics Inc"}],"pos":15},{"Field":[{"name":"sourceId","type":"string","value":"443856"},{"name":"corporatePublicationTitle","type":"string","value":"Drug development pipeline: MorViva"},{"name":"corporatePublicationType","type":"string","value":"Company Communication"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2002-03-18T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"Pain Therapeutics Inc"}],"pos":16},{"Field":[{"name":"sourceId","type":"string","value":"460461"},{"name":"corporatePublicationTitle","type":"string","value":"Information for shareholders on the progress of the Canadian cancer pain trial"},{"name":"corporatePublicationType","type":"string","value":"Company Publication"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2002-03-27T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"International Wex Technologies Inc"}],"pos":17},{"Field":[{"name":"sourceId","type":"string","value":"462649"},{"name":"corporatePublicationTitle","type":"string","value":"Making waves with solutions in pain management"},{"name":"corporatePublicationType","type":"string","value":"Annual Report"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2002-03-31T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"International Wex Technologies Inc"}],"pos":18},{"Field":[{"name":"sourceId","type":"string","value":"453915"},{"name":"corporatePublicationTitle","type":"string","value":"Enhance.L: Pain relief for OBGYN procedures"},{"name":"corporatePublicationType","type":"string","value":"Company World Wide Web site"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2002-06-07T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"Enhance Pharmaceuticals Inc"}],"pos":19},{"Field":[{"name":"sourceId","type":"string","value":"455033"},{"name":"corporatePublicationTitle","type":"string","value":"Sedation and Pain Relief"},{"name":"corporatePublicationType","type":"string","value":"Company World Wide Web site"},{"name":"corporatePublicationDatePublication","type":"datetime","value":"2002-06-18T00:00:00Z"},{"name":"corporatePublicationCompanyOwnerName","type":"string","value":"Orion Pharma"}],"pos":20}]},"DatasetCounts":[],"HitTerms":{"Term":[{"value":"pain"}],"Synonym":[{"value":"acute pain"},{"value":"acute pain indication"},{"value":"analgesia"},{"value":"chronic pain"},{"value":"chronic pain indication"},{"value":"lesion pain"}]},"serviceExecutionTime":16}